González-Billalabeitia, Enrique
Conteduca, Vincenza
Wetterskog, Daniel
Jayaram, Anuradha
Attard, Gerhardt
Funding for this research was provided by:
Prostate Cancer UK (PG12-49)
Article History
Received: 10 June 2018
Revised: 21 August 2018
Accepted: 8 September 2018
First Online: 9 November 2018
Compliance with ethical standards
:
: GA is on the ICR list of rewards to inventors for abiraterone. GA has received honoraria, consulting fees, or travel support from Astellas, Medivation, Janssen, Millennium Pharmaceuticals, Ipsen, Ventana, ESSA Pharmaceuticals, and Sanofi-Aventis and grant support from Janssen, AstraZeneca, and Arno. EG-B has received speaker honoraria or travel support from Astellas, Janssen-Cilag and Sanofi- Aventis. The other authors declare that they have no conflict of interest.